News

Filter

Current filters:

Sigma-Tau

Teijin inks exclusive deal with Sigma-Tau for EZN-2279 in Japan

Teijin inks exclusive deal with Sigma-Tau for EZN-2279 in Japan

26-06-2014

Japanese firm Teijin has entered into an agreement with the UK subsidiary of privately-owned Italian…

EZN-2279ImmunologicalsJapanLicensingPharmaceuticalSigma-TauTeijin

Soligenix shares decimated as firm puts hold on orBec development

20-09-2011

New Jersey, USA-based Soligenix (OTCBB: SNGX) saw its shares plummet 85% to just $0.03 last week, after…

Gastro-intestinalsLicensingorBecPharmaceuticalResearchSigma-TauSoligenix

Dyax expands Sigma-Tau territories for Kalbitor for $7M upfront

01-06-2011

USA-based Dyax Corp (Nasdaq: DYAX) says it has expanded the geographic reach of Defiante Farmaceutica,…

Dyax CorpKalbitorLicensingPharmaceuticalRare diseasesSigma-Tau

Dyax licenses HAE drug Kalbitor rights to Sigma-Tau for a potential $105 million

22-06-2010

USA-based Dyax Corp has entered a strategic partnership with Defiante Farmaceutica, as subsidiary of…

Dyax CorpKalbitorLicensingPharmaceuticalRare diseasesSigma-Tau

COMPANY SPOTLIGHT

Menarini

Back to top